|
Renin Inhibitors: A Novel Approach to HypertensionPublished by: Decision Resources Published: Jun. 23, 2006 - 17 Pages Price reduced due to age.Table of Contents
AbstractHypertension, or high blood pressure, is a significant health concern worldwide. It is a major risk factor for cardiovascular disease, and poorly controlled hypertension can damage target organs, eventually resulting in heart failure, end-stage kidney disease, retinopathy, stroke, and vascular dementia. The hypertension therapy market is also one of the largest markets in the world for prescription drugs. In this report, we examine a new class of antihypertensive drug, renin inhibitors. The first of these agents, aliskiren (Novartis/Speedel’s Rasilez), is preregistered in the United States. If approved, it will be the first of a new class of antihypertensive drug to enter the market in more than a decade.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||